Kim SH, Cairns N, Fountoulakisc M, Lubec G.

Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease.

Neurosci Lett 2001;300(1):41-44

Kinoshita Y, Ueyama T, Senba E, Terada T, Nakai K, Itakura T.

Expression of c-fos, heat shock protein 70, neurotrophins, and cyclooxygenase-2 mRNA in response to focal cerebral ischemia/reperfusion in rats and their modification by magnesium sulfate.

J Neurotrauma 2001;18(4):435-445

Koutsilieri E, Meulen VT, Riederer P.

Neurotransmission in HIV associated dementia: a short review. J Neural Transm 2001;108(6):767-775

Kowaluk et al., Jarvis MF.

Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs 2000;9(3):551-564

Kratzsch T, Peters J, Frolich L.

[Etiology and pathogenesis of Alzheimer dementia] Wien Med Wochenschr 2002;152(3-4):72-76

Krugers HJ, Maslam S, Korf J, Joels M, Holsboer F.

The corticosterone synthesis inhibitor metyrapone prevents hypoxia/ischemia- induced loss of synaptic function in the rat hippocampus.

Stroke 2000;31(5):1162-72

Kunugi H, Akahane A, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al.

No evidence for an association between the Glu298Asp polymorphism of the NOS3 gene and Alzheimer's disease.

J Neural Transm 2000;107(8-9):1081-1084

Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, Nabika T, et al.

A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease.

Mol Psychiatry 2001;6(1):83-86

Kwon KY, Jeon BC.

Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage.

J Korean Med Sci 2001;16(6):774-80

Kyomen HH, Hennen J, Gottlieb GL, Wei JY.

Estrogen therapy and noncognitive psychiatric signs and symptoms in elderly patients with dementia. Am J Psychiatry 2002;159(7):1225-1227

Lackey BR, Gray SL, Henricks DM.

Actions and interactions of the IGF system in Alzheimer's disease: review and hypotheses. Growth Horm IGF Res 2000;10(1):1-13

Lacombe C, Mayeux P.

The molecular biology of erythropoietin. Nephr Dial Transpl 1999;14 Supp 2:22-8

Lam AG, Koppal T, Akama KT, Guo L, Craft JM, Samy B, et al.

Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol Aging 2001;22(5):765-772

Lambert J, Harris J, Mann D, Lemmon H, Coates J, Cumming A, St-Clair D, et al.

Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett 2001;306(3):193-197

Lanctot KL, Herrmann N, Mazzotta P.

Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 2001;13(1):5-21

Laudenbach V, Medja F, Zoli M, Rossi FM, Evrard P, Changeux JP, Gressens P.

Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries.

FASEB J 2002;16(3):423-25

Lecerf JM, et al.

Human single-chain Fv untrabodies counteract in situ hintingtin aggregations in cellular models of Huntington’s disease.

PNAS USA 2001; 86:4764-4769

Law A, Gauthier S, Quirion R.

Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.

Brain Res Brain Res Rev 2001;35(1):73-96

Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH.

Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000;405(6784): 360-364

Leker RR, Teichner A, Ovadia H, Keshet E, Reinherz E, Ben-Hur T.

Expression of endothelial nitric oxide synthase in the ischemic penumbra: relationship to expression of neuronal nitric oxide synthase and vascular endothelial growth factor.

Brain Res 2001;909(1-2):1-7

Lesort M, Chun W, Tucholski J, Johnson GV.

Does tissue transglutaminase play a role in Huntington's disease? Neurochem Int 2002;40(1):37-52

Letechipia-Vallejo G, Gonzalez-Burgos I, Cervantes M.

Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats.

Arch Med Res 2001;32(3):186-192

Li H, Klein G, Sun P, Buchan AM.

Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia. Brain Res 2001;888(2):263-266

Li H, Li SH, Johnston H, Shelbourne PF, Li XJ.

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity.

Nat Genet 2000;25(4):385-389.

Liang Z, Valla J, Sefidvash-Hockley S, Rogers J, Li R.

Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients.

J Neurochem 2002;80(5):807-814

Lin TN, Nian GM, Chen SF, Cheung WM, Chang C, Lin WC, Hsu CY.

Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2001;21(6):690-701

Liu XF, Fawcett JR, Thorne RG, Frey WH 2nd.

Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion.

Neurosci Lett 2001;308(2):91-94

Lleo A, Blesa R, Gendre J, Castellvi M, Pastor P, Queralt R, Oliva R.

A novel presenilin 2 gene mutation (D439A) in a patient with et al.rly-onset Alzheimer's disease. Neurology 2001;57(10):1926-1928

Lorton D, Schaller J, Lala A, De Nardin E.

Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. Neurobiol Aging 2000;21(3):463-473

Lu A, Ran RQ, Clark J, Reilly M, Nee A, Sharp FR.

17-beta-estradiol induces heat shock proteins in brain arteries and potentiates ischemic heat shock protein induction in glia and neurons.

J Cereb Blood Flow Metab 2002;22(2):183-195

Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI.

Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease.

Hum Genet 2000;106(5):565-569

Не нашли, что искали? Воспользуйтесь поиском по сайту: